LexDanaLexDanabeta
Inventor

Makoto Kamata

Inventor
Kanagawa, JP

Overview

34→
Patents
2007–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 34 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes27%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
C07BGeneral methods of organic chemistry4%
C07CAcyclic or carbocyclic compounds1%
C12NMicroorganisms or enzymes1%
PatentTitleYear
10,899,7522,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor202110,865,200Nitrogen-containing heterocyclic compound202010,807,987Heterocyclic compound and use thereof202010,548,899Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activity202010,457,670Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimers disease201910,428,056Heterocyclic compound201910,323,0272,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor201910,208,046Nitrogen-containing heterocyclic compound201910,131,653Heterocyclic compound201810,106,556Heterocyclic compound201810,087,150Heterocyclic compound20189,878,989'Heterocyclic compound'20189,868,725'Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimer\'s disease'20189,789,084'Nitrogen-containing heterocyclic compound'20179,789,083'Nitrogen-containing heterocyclic compound'20179,777,005'Bicyclic heterocyclic compound containing a substituted pyrrole ring'20179,775,827'Nitrogen-containing heterocyclic compound'20179,732,086'Bicyclic heterocyclic compound containing a substituted pyrrole ring'20179,675,597'Nitrogen-containing heterocyclic compound'20179,662,316'Nitrogen-containing heterocyclic compound'20179,655,881'Nitrogen-containing heterocyclic compound'20179,518,042'Nitrogen-containing heterocyclic compound'20169,499,516'Nitrogen-containing heterocyclic compound'20169,315,458'Nitrogen-containing heterocyclic compound'20169,226,921'Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors'20168,940,758'Fused heterocyclic compounds'20158,901,309'Fused triazoles for the treatment or prophylaxis of mild cognitive impairment'20148,846,713'Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitors'20148,822,699'Heterocyclic compound and use thereof'20148,703,758'Bicyclic compound'20148,563,575'Fused heterocyclic compounds'20138,501,804'Bicyclic compound'20137,601,868'Amine derivative'20097,183,415'Quinoline compound'2007

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2007–2016Patents assigned to TAKEDA PHARMACEUTICAL (11)· patent assignee history
2007–2014Based in Osaka, JP· patent location history
2013–2014Patents assigned to KAMATA MAKOTO (6)· patent assignee history
2013–2014Patents assigned to HASUI TOMOAKI (2)· patent assignee history
2013–2014Patents assigned to HONDA EIJI (2)· patent assignee history
2013–2021Based in Kanagawa, JP· patent location history
2016–2021Patents assigned to TAKEDA PHARMACEUTICALS CO (22)· patent assignee history
2018–2020Based in Fujisawa, JP· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
TAKEDA PHARMACEUTICALS CO222016–2021
TAKEDA PHARMACEUTICAL112007–2016
KAMATA MAKOTOself62013–2014
HASUI TOMOAKI22013–2014
HONDA EIJI22013–2014
Locations
LocationPatentsSpan
Kanagawa, JP272013–2021
Osaka, JP42007–2014
Fujisawa, JP32018–2020